fsoalex, I think sean007's thought on them(CYDY) responding with the article reporting the list of the endpoints that were achieved against the FDA's article was probably the safest response from the companies perspective. I'm sure, if not just hoping, that some regulatory group will help the FDA reevaluate the way they handled this pandemic and adjust their process moving forward. At least when it comes to an emergency. Outside of that I think if and when the rest of the world moves forward with EUA's or approval of LL, the regulatory agency of the FDA will have some Q's especially why is an american company approved for use abroad but not at home to help possibly save lives here and what led you to the decision not to issue at least a working EUA as they did with other drugs.